Cover Image
市場調查報告書

粉刺用醫藥品的全球市場:2016∼2020年

Global Acne Drugs Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 345478
出版日期 內容資訊 英文 84 Pages
訂單完成後即時交付
價格
Back to Top
粉刺用醫藥品的全球市場:2016∼2020年 Global Acne Drugs Market 2016-2020
出版日期: 2015年11月18日 內容資訊: 英文 84 Pages
簡介

全球粉刺用醫藥品市場預計2020年以年複合成長率3%踏實成長。由於生活習慣的變化造成粉刺產產生為促進市場擴大的主要原因。局部用藥物佔2015年的市場54%的佔有率。使用容易、副作用少、容易取得為主要理由。

本報告提供全球粉刺用醫藥品市場相關調查、該市場的到現狀與至2020年的成長前景、各類藥物/各給藥途徑趨勢/各地區市場佔有率、主要供應商概要、市場課題與趨勢等彙整資料。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

第5章 粉刺:概要

  • 疾病的理解
  • 病理學
  • 原因
  • 粉刺的種類
  • 粉刺的影響
  • 管理
  • 流行病學

第6章 開發平台分析

第7章 市場情況

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第8章 粉刺用醫藥品方案

第9章 各藥物市場區隔

  • 抗生劑
  • 抗發炎劑
  • 抗菌劑
  • 並用藥物
  • 荷爾蒙劑
  • 口服類視色素
  • 局部類視色素

第10章 各給藥途徑市場區隔

  • 局部
  • 口服

第11章 各類型市場區隔

  • 處方藥
  • OTC藥

第12章 全球粉刺用醫藥品市場:OTC藥

  • 主要產品
  • 有害的影響
  • 主要供應商
  • 歐洲市場

第13章 各地區市場區隔

  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第14章 推動市場的要素

  • 粉刺的罹患率
  • 生活習慣的變化
  • 龐大的未滿足需求
  • 有希望開發平台
  • 可支配所得的提高

第15章 促進要素的影響

第16章 市場課題

第17章 促進要素與課題的影響

第18章 市場趨勢

  • 聯合治療
  • 認識計劃
  • 產品創新
  • 超過處方藥的OTC藥使用率
  • OTC藥的行銷

第19章 供應商環境

  • 競爭模式
  • 2015年的市場佔有率分析
  • Valeant Pharmaceuticals
  • Galderma
  • Allergan
  • Stiefel Laboratories
  • 其他值得注意的供應商

第20章 附錄

第21章 關於Technavio

圖表

目錄
Product Code: IRTNTR7887

Covering: This market research report presents a detailed segmentation of the global acne drugs market by drug class (antibiotics, anti-inflammatory drugs, antimicrobial, combination medications, hormonal agents, oral retinoid, and topical retinoid), by route of administration (topical, and oral), and by type (prescription and OTC). It outlines the market shares for key regions such as the Americas, APAC, and EMEA. The key vendors analyzed in this report are Allergan, Galderma, Stiefel, and Valeant.

Market outlook of acne drugs

Technavios market research analyst predicts the global acne drugs market to grow steadily at a CAGR of approximately 3% during the forecast period. The occurrence of acne due to lifestyle changes is the primary driver for the market. Sedentary lifestyle and unhealthy food habits lead to hormonal problems, which trigger the development of acne. Lack of sleep, emotional and work-related stress, smoking, drug abuse, and alcohol consumption are major triggers for the occurrence of acne among teenagers and adults.

The rise in disposable income has encouraged consumers, especially the middle-class income group, to spend more on personal care products. The rising awareness of acne and the current and upcoming treatments is expected to drive the acne drugs market through the forecast period. Women particularly, play a crucial role in this market as the demand generated by them influences the market growth considerably.

Segmentation by drug class and analysis of the acne drugs market

  • Antibiotics
  • Anti-inflammatory drugs
  • Antimicrobial
  • Combination medications
  • Hormonal agents
  • Oral retinoid
  • Topical retinoid

Acne medication depends on the skin type and the severity of the condition. For instance, oral retinoid agents are considered as the appropriate treatment for severe acne. These drugs help prevent excessive oil production, bacterial acne growth, and inflammation.

Segmentation by method of administration and analysis of the acne drugs market

  • Topical
  • Oral

The topical drugs segment dominated the market during 2015, accounting for a market share of around 54%. Ease of application, low systemic side-effects, and easy availability of these products are the primary drivers for the growth of this segment.

Segmentation by type and analysis of the acne drugs market

  • Prescription drugs
  • OTC drugs

Prescription drugs dominated the market during 2015 due to the increased awareness about acne and the treatments options, especially in the developed countries. For instance, Epiduo, Benzaclin, and Duac are some of the popular acne prescription drugs available in the market.

Segmentation by geography and analysis of the acne drugs market

  • Americas
  • APAC
  • EMEA

The Americas accounted for around 90% of the market share during 2015 but is expected to witness a decline in sales during the forecast period. Lifestyle changes, increase in awareness programs about acne, and availability of acne treatment options are the primary drivers for market growth in this region.

Competitive landscape and key vendors

The global acne drugs market is dominated by key vendors. The availability of OTC drugs and the preference for alternative therapies for treating acne has been restricting the sales of branded acne products. Vendors in this market are anticipated to invest heavily on R&D during the forecast period.

The leading vendors in the market are -

  • Allergan
  • Galderma
  • Stiefel
  • Valeant

The other prominent vendors in the market include AndroScience, Anterios, Aqua Pharmaceuticals, Astellas, Bayer HealthCare, BioPharmX, Celtaxsys, Cipher Pharmaceuticals, COSMO Pharmaceuticals, Dermira, Elorac, F.Hoffmann-La Roche, Foamix, GlaxoSmithKline, Guthy-Renker, Helix BioMedix, Hygeia Therapeutics, Johnson & Johnson, Meda, Mylan, Novan, Oculus Innovative Sciences, Paratek Pharmaceuticals, Photocure, Promius Pharma, Ranbaxy, Reckitt Benckiser, Skinvisible Pharmaceuticals, Teva, Versapharm, and XBiotech.

Key questions answered in the report include

  • What will the market size and the growth rate be in 2020
  • What are the key factors driving the global acne drugs market
  • What are the key market trends impacting the growth of the acne drugs market
  • What are the challenges to market growth
  • Who are the key vendors in this market space
  • What are the market opportunities and threats faced by the vendors in the global acne drugs market
  • What are the trending factors influencing the market shares of the Americas, APAC, and EMEA
  • What are the key outcomes of the five forces analysis of the acne drugs market

Technavio also offers customization on reports based on specific client requirement.

Related reports:

  • Global Shaving Lotions and Creams Market 2015-2019
  • Global Dermatology Diagnostic Devices Market- Industry Analysis 2015-2019
  • Global Energy-based Therapeutics Market - Industry Analysis 2015-2019

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Acne: An overview

  • Understanding the disease
  • Pathophysiology
  • Causes
  • Types of acne
  • Implications of acne
  • Management
  • Epidemiology

PART 06: Pipeline analysis

  • Sarecycline
  • IDP-121
  • CB-03-01
  • IDP-120
  • CB-06-04
  • ASC-J9
  • Visonac
  • DRM-01
  • FMX101
  • True human antibody RA-18C3
  • SB204
  • Acebilustat
  • ANT-1207

PART 07: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 08: Reimbursement scenario for acne drugs

PART 09: Market segmentation by drug class

  • Antibiotics
  • Anti-inflammatory drugs
  • Antimicrobials
  • Combination drugs
  • Hormonal agents
  • Oral retinoids
  • Topical retinoids

PART 10: Market segmentation by route of administration

  • Topical
  • Oral

PART 11: Market segmentation by type

  • Prescription drugs
  • OTC drugs

PART 12: Global acne drugs market: OTC drugs

  • Major acne OTC products
  • Adverse effects of OTC acne drugs
  • Major vendors of OTC acne drugs
  • OTC acne drugs market in Europe

PART 13: Geographical segmentation

  • Acne drugs market in Americas
  • Global acne drugs market in EMEA
  • Acne drugs market in APAC

PART 14: Market drivers

  • Prevalence of acne
  • Lifestyle changes
  • Significant unmet medical needs
  • Promising drug pipeline
  • Rise in disposable income

PART 15: Impact of drivers

PART 16: Market challenges

  • Adverse effects of drugs
  • Poor patient adherence
  • Preference for alternative therapies
  • Intense market competition

PART 17: Impact of drivers and challenges

PART 18: Market trends

  • Preference for combination therapies
  • Acne awareness programs
  • Product innovations
  • Increased use of OTC products over prescription drugs
  • Marketing of OTC acne products

PART 19: Vendor landscape

  • Competitive scenario
  • Market share analysis 2015
  • Valeant Pharmaceuticals
  • Galderma
  • Allergan
  • Stiefel Laboratories
  • Other prominent vendors

PART 20: Appendix

  • List of abbreviations

PART 21: Explore Technavio

  • List of Exhibits
  • Exhibit 01: Product offerings
  • Exhibit 02: Acne drugs: Key buying criteria
  • Exhibit 03: Types of acne based on severity
  • Exhibit 04: Types of acne based on severity of inflammation
  • Exhibit 05: Implications of acne
  • Exhibit 06: Treatment algorithm: Management of acne
  • Exhibit 07: Acne drugs: Pipeline portfolio
  • Exhibit 08: Global acne drugs market 2015-2020 ($ millions)
  • Exhibit 09: Five forces analysis
  • Exhibit 10: Oral prescription acne drugs: Reimbursement by payers in US 2014
  • Exhibit 11: Topical prescription acne drugs: Reimbursement by payers in US 2014
  • Exhibit 12: Global acne drugs market segmentation by drug class
  • Exhibit 13: Global acne drugs market segmentation by route of administration
  • Exhibit 14: Global acne drugs market segmentation by route of administration 2015
  • Exhibit 15: Revenue of topical prescription drugs in US 2015
  • Exhibit 16: Revenue of oral prescription drugs in US 2015
  • Exhibit 17: Global acne drugs market segmentation by type
  • Exhibit 18: Global acne drugs market segmentation by type 2015
  • Exhibit 19: OTC drugs: Advantages and disadvantages
  • Exhibit 20: AcneFree by Valeant Pharmaceuticals: SWOT analysis
  • Exhibit 21: Clearasil by Reckitt Benckiser: SWOT analysis
  • Exhibit 22: Clean & Clear by Johnson & Johnson: SWOT analysis
  • Exhibit 23: Neutrogena by Johnson & Johnson: SWOT analysis
  • Exhibit 24: Proactiv by Guthy-Renker: SWOT analysis
  • Exhibit 25: Global acne drugs market segmentation by geography 2015
  • Exhibit 26: Global acne drugs market segmentation by geography 2015-2020 ($ millions)
  • Exhibit 27: Acne drugs market in Americas 2015-2020 ($ millions)
  • Exhibit 28: Acne drugs market in US 2015-2020 ($ millions)
  • Exhibit 29: Acne drugs market in EMEA 2015-2020 ($ millions)
  • Exhibit 30: Acne drugs market in APAC 2015-2020 ($ millions)
  • Exhibit 31: Impact of drivers
  • Exhibit 32: Impact of drivers and challenges
  • Exhibit 33: Ranking of leading vendors 2015
  • Exhibit 34: Valeant Pharmaceuticals: Business segmentation by revenue 2014
  • Exhibit 35: Valeant Pharmaceuticals: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 36: Valeant Pharmaceuticals: Product segmentation by revenue 2014
  • Exhibit 37: Valeant Pharmaceuticals: Geographical segmentation by revenue 2014
  • Exhibit 38: Valeant Pharmaceuticals: SWOT analysis
  • Exhibit 39: Galderma: Therapeutic categories
  • Exhibit 40: Galderma: SWOT analysis
  • Exhibit 41: Allergan: Business segmentation by product revenue 2014
  • Exhibit 42: Allergan: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 43: Allergan: Geographical segmentation by revenue 2014
  • Exhibit 44: Allergan: SWOT analysis
  • Exhibit 45: Stiefel Laboratories: Product categories
  • Exhibit 46: Stiefel Laboratories: SWOT analysis
Back to Top